The present invention relates to a biomarker and {TAIL ~ method} for identifying {HEAD ~ the subgroup} of early stage lung adenocarcinoma patients in early stage NSCLC, which is helpful for the design of clinical trials for adjuvant therapy 
The present invention relates to a biomarker and { TAIL ~ method } for identifying { HEAD ~ the subgroup } of early stage lung adenocarcinoma patients in early stage NSCLC , which is helpful for the design of clinical trials for adjuvant therapy
OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH